DEXCOM INC — Director's Dealing 2019

Jun 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2019-06-13

Reporting Person: Leach Jacob Steven (EVP Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-13	Common Stock	S	4499	$145.1949	Disposed	116381	Direct
2019-06-13	Common Stock	S	600	$146.2933	Disposed	115781	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11824	Indirect

Footnotes

F1: On March 13, 2019, the reporting person adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $144.99 to $145.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Included in this number are 42,760 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 20,062 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,711 of which were granted on March 8, 2017 and shall vest through March 8, 2020.

F4: This transaction was executed in multiple trades at prices ranging from $146.00 to $146.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.